Study on influence of drugs on antiplatelet effects of aspirin.
Not Applicable
- Conditions
- Healthy volunteers
- Registration Number
- JPRN-UMIN000010881
- Lead Sponsor
- aboratory of pharmacotherapeutics, Tokyo University of Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Subjects who have donated 200 mL blood within 1 month, or 400 mL blood within 3 month. 2)Subjects who have taken aspirin or drugs with antiplatelet effect within 1 week. 3)Subjects with hypertension or hypotension. 4)Subjects with poor condition on a blood collecting day. 5)Subjects whom the doctor considered to be unsuitable for this study. 6)Subjects who are unable to put restrictions on diets (ex. foods and drinks are prohibited within 4 hours prior to blood collection, high fat meals should be avoided since 1 day before blood collection).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet aggregation activity(Platelet Aggregation Threshold Index:PATI)
- Secondary Outcome Measures
Name Time Method Serum thromboxane B2 concentration